Natural products to drugs: natural product-derived compounds in clinical trials

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2005 Australia English Publisher:Royal Society of Chemistry (RSC)Journal:Natural Product Reports, volume 25, page 475 (issn: 0265-0568, eissn: 1460-4752,

Copyright policy )

Authors: Butler, Mark S.;

doi: 10.1039/b514294f , 10.1002/chin.200531234 , 10.1039/b402985m

pmid: 15806196 , 18497896

Natural products to drugs: natural product-derived compounds in clinical trials

- Summary
- Subjects
- Metrics

Abstract

AbstractFor Abstract see ChemInform Abstract in Full Text.

Country

Australia

Related Organizations

National University of Singapore
Singapore
Singapore Science Park
Singapore
University of Queensland
Australia
University of Queensland
Australia

Keywords

Biological Products, Clinical Trials as Topic, 1303 Biochemistry, Drug Industry, Molecular Structure, 3002 Drug Discovery, Natural product templates, Natural product, Natural product-derived compounds, Pharmaceutical Preparations, 1605 Organic Chemistry

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1K
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 0.1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 0.1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 0.1%